0001140361-17-047643.txt : 20171228 0001140361-17-047643.hdr.sgml : 20171228 20171228183857 ACCESSION NUMBER: 0001140361-17-047643 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171213 FILED AS OF DATE: 20171228 DATE AS OF CHANGE: 20171228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CPMG Inc CENTRAL INDEX KEY: 0001372218 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37785 FILM NUMBER: 171279403 BUSINESS ADDRESS: STREET 1: 2000 MCKINNEY STREET 2: SUITE 2125 CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: 214-871-6816 MAIL ADDRESS: STREET 1: 2000 MCKINNEY STREET 2: SUITE 2125 CITY: DALLAS STATE: TX ZIP: 75201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001358762 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113651945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 BUSINESS PHONE: 972-865-2206 MAIL ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 4/A 1 form4.xml X0306 4/A 2017-12-13 2017-12-15 0001358762 REATA PHARMACEUTICALS INC RETA 0001372218 CPMG Inc 2000 MCKINNEY AVE., STE 2125 DALLAS TX 75201 true true Class A common stock 2017-12-13 4 P 0 19982 24.8838 A 19982 I By Managed Account for Trustees of the University of Pennsylvania Class A common stock 2017-12-13 4 P 0 49 23.9767 A 20031 I By Managed Account for Trustees of the University of Pennsylvania Class A common stock 2017-12-14 4 P 0 14866 24.6528 A 34897 I By Managed Account for Trustees of the University of Pennsylvania Class A common stock 442560 I By Gallopavo, LP This price reflects the weighted average purchase price for open-market purchases on December 13, 2017, within a $1.00 range. The actual prices for these transactions range from $24.08 to $25.08 inclusive. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4. This price reflects the weighted average purchase price for open-market purchases on December 13, 2017, within a $1.00 range. The actual prices for these transactions range from $23.97 to $23.99 inclusive. This price reflects the weighted average purchase price for open-market purchases on December 14, 2017, within a $1.00 range. The actual prices for these transactions range from $24.40 to $24.92, inclusive. The Reporting Person is the investment manager of each of Gallopavo, LP and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. On December 15, 2017, the Reporting Persons inadvertently reported that these shares were purchased for the account of Gallopavo, LP. As correctly noted on this amendment, the shares were purchased for a managed account for Trustees of the University of Pennsylvania. Gallopavo, LP has not engaged in trades since the report filed by the Reporting Persons on June 23, 2017. Mr. McGaughy, Jr., a co-director and co-shareholder of the Reporting Person, serves on the Issuer's Board of Directors (the "Board") as a representative of the Reporting Person. By virtue of his representation on the Board, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the Reporting Person is deemed to be a director by deputization. /s/ John Bateman, Chief Operating Officer of CPMG, Inc. 2017-12-28